During the past decade, Charlotte Gastroenterology & Hepatology, PLLC conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 11 clinical trials were completed, i.e. on average, 68.8% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Charlotte Gastroenterology & Hepatology, PLLC" #1 sponsor was "Abbott" with 4 trials, followed by "Bristol-Myers Squibb" with 4 trials sponsored, "Exact Sciences Corporation" with 3 trials sponsored, "Millennium Pharmaceuticals, Inc." with 3 trials sponsored and "Bausch Health Americas, Inc." with 3 trials sponsored. Other sponsors include 22 different institutions and companies that sponsored additional 26 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Charlotte Gastroenterology & Hepatology, PLLC" #1 collaborator was "Gilead Sciences" with 2 trials as a collaborator, "Agency for Healthcare Research and Quality (AHRQ)" with 1 trials as a collaborator, "Athersys, Inc" with 1 trials as a collaborator, "Atlanta Gastroenterology Associates" with 1 trials as a collaborator and "Brigham and Women's Hospital" with 1 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Charlotte Gastroenterology & Hepatology, PLLC" are "Crohn's Disease" (17 trials), "Ulcerative Colitis" (7 trials), "Colorectal Cancer" (4 trials), "Colitis, Ulcerative" (3 trials) and "Crohn Disease" (3 trials). Many other conditions were trialed in "Charlotte Gastroenterology & Hepatology, PLLC" in a lesser frequency.

Most popular intervention types in "Charlotte Gastroenterology & Hepatology, PLLC" are "Drug" (35 trials), "Other" (4 trials), "Biological" (2 trials), "Behavioral" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (16 trials), "placebo" (4 trials), "vedolizumab" (3 trials), "Etrolizumab" (2 trials) and "Filgotinib" (2 trials). Other intervention names were less common.

The vast majority of trials in "Charlotte Gastroenterology & Hepatology, PLLC" are 43 trials for "All" genders.

Currently, there are NaN active trials in "Charlotte Gastroenterology & Hepatology, PLLC". undefined are not yet recruiting, 3 are recruiting, 4 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 32 completed trials in Charlotte Gastroenterology & Hepatology, PLLC, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Charlotte Gastroenterology & Hepatology, PLLC, 0 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".